Visa and Mastercard are at their most reasonable valuations in nearly a decade while remaining as dominant as ever. The duopoly takes a small slice of nearly every digital payment worldwide, with no credit risk, near-unbeatable moats and legendary margins. In the 2021 bubble they traded at 50-60 times free cash flow, leaving little margin of safety; normalization and temporary headlines have cut that to the mid-to-high 20s. A rare chance to buy two elite compounders at a steep discount. x.com 

Mastercard may be the only scaled, capital-light network benefiting from AI, with bloated technical debt uniquely addressable by coding tools. Nominal inflation-linked recurring revenues and hardware attach add to the case at low-teens free-cash-flow yields. While payments getting bid in a red market probably signals the rally is over, these traits could mean it is not. x.com 

Visa's roughly 30x earnings multiple and $750 billion valuation leave less upside than other opportunities, even if it keeps executing; the best case may be another doubling over a few years. Its once-impenetrable moat may look different in five years, while its reputation as a safe compounder is already priced in. This is a relative judgment, not a prediction that Visa cannot keep rising. x.com  x.com  x.com  x.com  x.com 

Mastercard rarely goes on sale and is now a world-class compounder at one of its least demanding valuations in years. It trades at 21.8x EV/EBIT, barely above its lowest valuation since 2018 and less than half its 2021 peak multiple. x.com  x.com 

Mastercard looks remarkably cheap: at a 21.5 forward P/E per Finviz, it sits about 43% below its 10-year average of 37.5. x.com 

Mastercard is worth about $473 per share on 13% growth in years one to five, with a conservative case of $342 and an optimistic case of $596. The wide range depends on whether near-term growth in payment volumes holds. x.com 

Visa and Mastercard look like attractive, safe cash machines at decade-low valuations, likely compounding 10-15% a year from here. Mastercard trades at 23x forward earnings, its lowest in a decade, and Visa at 22x; Mastercard just bounced off its 200-week moving average, untouched since 2022. They will not 10x in ten years but should protect the downside. Visa is slightly preferred for its sheer size, though Mastercard grows faster. x.com 

Visa and Mastercard are priced for a disruption that looks overdone, leaving two of the best compounders at decade-low multiples. Mastercard trades 34% below its 10-year median P/E, and Visa is similar. Stablecoins are about 2% of Visa's volume and years from replacing daily card use. The Credit Card Competition Act could cut fees from about 1.8-2.0% to 1.25%, with $10 billion-plus of industry revenue at stake, but analysts put its passage odds at 30-40%. x.com 

S&P Global, Mastercard, Visa, Moody's and Berkshire Hathaway have turned from portfolio ballast into funding shorts. These EPS compounders once pulled portfolios up alongside spicier longs, but they are never particularly cheap, Visa may rise only 4-5% on great earnings, and they can't be taken out. For most investors' horizons they are irrelevant next to momentum stocks that gap up 30% on narratives, so owning them now means being long funding shorts. That could change. x.com  x.com 

Mastercard's payment and earnings growth make it more satisfying than ever to own amid Alphabet's and Amazon's post-earnings reactions. Q3 2026 revenue rose 14% to $9.8 billion, adjusted EPS rose 21% to $5.31, and adjusted operating margin was 60.5%. Volume grew 7%, cross-border volume 11%, and $3.8 billion went to shareholders through buybacks and dividends. x.com